Operating margin moved 576 bp higher
Operating margin changed +576 basis points from the comparable as-filed period.
-176.24%→-170.48%2 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →CSAI financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Gross margin moved 1241 bp higher
Gross margin changed +1241 basis points from the comparable as-filed period.
37.06%→49.47%2 prior comparisons
Research & development increased 50.4%
Research & development changed +50.4% from the comparable as-filed period.
$379,000→$570,0002 prior comparisons
Cash & equivalents decreased 50.8%
Cash & equivalents changed -50.8% from the comparable as-filed period.
$7.7M→$3.8M3 prior comparisons
Gross profit increased 51.0%
Gross profit changed +51.0% from the comparable as-filed period.
$404,000→$610,0002 prior comparisons
Trade receivables increased 104.4%
Trade receivables changed +104.4% from the comparable as-filed period.
$496,000→$1.0M3 prior comparisons
Inventory / revenue moved 1245 bp lower
Inventory / revenue changed -1245 basis points from the comparable as-filed period.
35.32%→22.87%2 prior comparisons
Current assets decreased 36.1%
Current assets changed -36.1% from the comparable as-filed period.
$8.9M→$5.7M3 prior comparisons
SBC / revenue moved 2043 bp lower
SBC / revenue changed -2043 basis points from the comparable as-filed period.
51.01%→30.58%2 prior comparisons
Stock-based compensation decreased 32.2%
Stock-based compensation changed -32.2% from the comparable as-filed period.
$556,000→$377,0003 prior comparisons
Total assets decreased 34.2%
Total assets changed -34.2% from the comparable as-filed period.
$9.1M→$6.0M3 prior comparisons
Working capital decreased 42.5%
Working capital changed -42.5% from the comparable as-filed period.
$7.9M→$4.5M3 prior comparisons
Inventory decreased 26.8%
Inventory changed -26.8% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$385,000→$282,0003 prior comparisons
Capex / revenue moved 1174 bp lower
Capex / revenue changed -1174 basis points from the comparable as-filed period.
11.01%→-0.73%2 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.